(Q39966817)

16 September 2017

Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis (English)

1 reference

16 September 2017

0 references

1 reference

0 references

4

1 reference

16 September 2017

7

Karin Jirström

1 reference

16 September 2017

Anna Dahlman

1

1 reference

16 September 2017

Elton Rexhepaj

2

1 reference

16 September 2017

Donal J Brennan

3

1 reference

16 September 2017

Alexander Gaber

5

1 reference

16 September 2017

Anna Lindgren

6

1 reference

16 September 2017

Anders Bjartell

8

1 reference

16 September 2017

14 January 2011

1 reference

16 September 2017

1 reference

16 September 2017

24

1 reference

16 September 2017

5

1 reference

16 September 2017

708-719

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2010.238

16 September 2017

0 references

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

An updated catalog of prostate cancer predictive tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Blood and tissue biomarkers in prostate cancer: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Three predominant proteins secreted by the human prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: comparison of its distribution in normal, benign and malignant prostates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Prognostic significance of beta-microseminoprotein mRNA expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Prognostic value of prostate secretory protein of 94 amino acids and its binding protein after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Multiple loci identified in a genome-wide association study of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Multiple newly identified loci associated with prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Mutation analysis of the MSMB gene in familial prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

beta-Microseminoprotein binds CRISP-3 in human seminal plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Characterization and localization of cysteine-rich secretory protein 3 (CRISP-3) in the human male reproductive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Cloning, expression, purification and functional characterization of recombinant human PSP94.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

The gene encoding the prostatic tumor suppressor PSP94 is a target for repression by the Polycomb group protein EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

7 January 2021

Cellular expression of beta-microseminoprotein (beta-MSP) mRNA and its protein in untreated prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

7 January 2021

In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

7 January 2021

Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

7 January 2021

A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

7 January 2021

A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.238

7 January 2021

10.1038/MODPATHOL.2010.238

Identifiers

DOI

1 reference

Dimensions Publication ID

16 September 2017

0 references

1 reference